Anika Therapeutics ANIK Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $57.48M+3.3% | $55.63M-19.1% | $68.74M-20.4% | $86.33M-8.5% | ||
| $23.69M+0.4% | $23.59M-10.5% | $26.36M-23.9% | $34.63M+16.0% | ||
| —— | —— | $1.1M+70.6% | $647K-97.8% | ||
| $18.79M-21.1% | $23.81M-2.5% | $24.43M-38.6% | $39.77M+10.4% | ||
| $103.36M-9.1% | $113.65M-30.4% | $163.31M-3.7% | $169.55M+0.6% | ||
| $40.32M+3.4% | $38.99M+4.1% | $37.45M-22.4% | $48.28M+1.4% | ||
| $8.05M+13.0% | $7.13M-5.9% | $7.57M+3.2% | $7.34M-5.7% | ||
| $1.65M-33.7% | $2.49M-3.3% | $2.58M-96.5% | $74.6M-9.4% | ||
| $190.27M-6.2% | $202.74M-25.1% | $270.63M-22.5% | $349.13M+0.5% | ||
| $6.04M+7.5% | $5.62M-9.3% | $6.19M-31.7% | $9.07M+18.9% | ||
| $21.91M-6.0% | $23.31M-25.0% | $31.06M+11.3% | $27.91M-6.3% | ||
| $139K-3.5% | $144K-2.0% | $147K+0.7% | $146K+1.4% | ||
| $60.79M-15.2% | $71.67M-44.0% | $128.05M-39.2% | $210.72M-6.6% | ||
| $143.47M-6.8% | $153.99M-27.5% | $212.27M-25.7% | $285.56M-0.5% | ||
| $190.27M-6.2% | $202.74M-25.1% | $270.63M-22.5% | $349.13M+0.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Anika Therapeutics's total assets?
- Anika Therapeutics (ANIK) holds $179.4M in total assets, down 5.9% year over year.
- How much debt does Anika Therapeutics have?
- Anika Therapeutics carries $25.7M in total debt against $133.9M of shareholders' equity, a debt-to-equity ratio of 0.19.
- How much cash does Anika Therapeutics have?
- Anika Therapeutics holds $41.0M in cash and equivalents.
- Can Anika Therapeutics cover its short-term obligations?
- Its current ratio is 4.46 — current assets exceed current liabilities.
- Where does Anika Therapeutics's balance sheet data come from?
- Every line is extracted from Anika Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
